Meto Review
Meto is no longer available as we reviewed it, so this page is kept for reference.
Meto: No longer offers GLP-1s; the site now sells peptide therapy. We're not linking to it. Here are the top-rated GLP-1 providers we recommend instead.
See our top-rated GLP-1 providers →Meto is an insurance-accepting metabolic telehealth platform offering compounded semaglutide and compounded tirzepatide, prescribed after clinician-ordered lab work. The platform matches patients with board-certified specialists (including endocrinologists, obesity medicine physicians, dietitians, and metabolic health coaches) within minutes, and manages all billing, prior-authorization, and insurance paperwork for major insurers (Blue Cross, Anthem, United Healthcare, Aetna). Most insured patients pay $0–50 per visit; self-pay rates exist but are not publicly disclosed.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to Meto
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Meto at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- What's included
- Medication · Consult · Labs · Coaching
- FDA status
- No FDA warning letter on record
How we scored Meto
Each dimension is scored algorithmically from Meto’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
6.3/10Meto no longer sells GLP-1 treatment, so no current price applies.
Effectiveness25%
8.1/10Meto offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.4/10Online intake and platform experience (consult included in the price); 8 platform features disclosed.
Trust & Safety15%
7.3/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
8.6/10Meto treats patients in all 50 states. Insurance pathways are offered for eligible patients.
Support10%
7.2/10Coaching/dietitian access included.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Meto review
Last checked August 2026- Noted its stated service area; it publishes no state-by-state list
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Meto
We walked Meto’s public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Start with an online assessment via Meto's intake quiz.
- 2Choose your path: a targeted treatment plan, a diagnostic test package, or a consult.
- 3Get a personalized medical plan from a provider.
- 4Follow your progress over time.
- Insurance-oriented model: average session cost with insurance stated as $25, most visits $0-50 with insurance.
- No explicit monthly medication/subscription price is shown before intake.
- Lab testing is optional; diagnostic panels range $199-$399.
- Virtual visits are said to be accepted by major insurers.
- Support appears email-only with no phone number or hours listed.
Meto customer support
- support@meto.co
GLP-1 medications Meto offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Peptides Meto offers
Beyond GLP-1s, Meto also offers these peptides. Tap any for our evidence-based guide.
What we like
- Accepts major insurance (Blue Cross, Anthem, United, Aetna), and most patients pay $0–50 per visit
- Requires lab work before prescribing GLP-1s; addresses root-cause metabolic drivers
- Matches patients with endocrinologists and obesity medicine specialists within minutes
- Offers compounded semaglutide and tirzepatide with board-certified physician oversight
- Handles all prior-auth paperwork; provider location pages exist for all 50 US states
Watch-outs
- Medication pricing shows only after the quiz, with no public cash price for semaglutide or tirzepatide
- Lab panels are a separate out-of-pocket cost ($199–$399) unless covered by insurance
- No LegitScript certification or named compounding pharmacy found on any public page
- Company leadership and clinical team not disclosed publicly
- The site says self-pay cash pricing exists, but it is not published anywhere
Is Meto still an option?
Meto no longer offers a GLP-1 weight-loss program, so there is nothing to sign up for today. We cannot quote a current price, because none exists. We keep this page online so past users can see what it offered and find a program that still operates.
If you were a Meto patient, talk with your prescriber before your remaining supply runs out. That keeps treatment going without a gap or an unsafe restart dose. Then compare current providers on price, medication and state coverage. Our page of Meto alternatives lists programs that still operate, and the ranked list of semaglutide providers shows where each one stands. If you need a new prescription, our guide on how to get a GLP-1 prescription walks through the steps.
The Bottom Line
Meto is no longer available as we reviewed it, so this page is kept for reference.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Meto review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.